Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
International Journal of Nanomedicine
|
June 3, 2024
Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy
Seonju Lee, Seon Ah Lee, Jongyoon Shinn, et al.
International Journal of Nanomedicine
|
January 2, 2026
Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes
Bom Lee, Jeeeun Yoo, Han Sol Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 29, 2026
Advanced engineering of microbiome-related therapeutics for targeted treatment of inflammatory bowel diseases
Yu Jeong Kim, Nayoon Park, Xiaoliang Cheng, et al.
Encephalitis (Seoul, Korea)
|
July 27, 2023
Optic neuritis associated with seronegative autoimmune encephalitis: a case report
Hyungseok Hah, Yonghyun Lee, Ho-Won Lee, et al.
Biomaterials
|
April 28, 2017
PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation
Min Jun Kim, Yonghyun Lee, Sangyong Jon, et al.
Biomacromolecules
|
May 2, 2018
Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy
Soyoung Lee, Yonghyun Lee, Hyungjun Kim, et al.
Pharmaceutics
|
November 4, 2020
Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
Yonghyun Lee, Jungyun Kim, Wooseong Kim, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
September 29, 2025
Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance
Xiaoliang Cheng, Peixing Wang, Hongqiang Lyu, et al.
Archives of Pharmacal Research
|
April 11, 2015
Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent
Wooseong Kim, Yonghyun Lee, Seongkeun Jeong, et al.
Angewandte Chemie (International Ed. in English)
|
May 5, 2016
Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy
Yonghyun Lee, Hyungjun Kim, Sukmo Kang, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
International Journal of Nanomedicine
|
June 3, 2024
Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy
Seonju Lee, Seon Ah Lee, Jongyoon Shinn, et al.
International Journal of Nanomedicine
|
January 2, 2026
Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes
Bom Lee, Jeeeun Yoo, Han Sol Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 29, 2026
Advanced engineering of microbiome-related therapeutics for targeted treatment of inflammatory bowel diseases
Yu Jeong Kim, Nayoon Park, Xiaoliang Cheng, et al.
Encephalitis (Seoul, Korea)
|
July 27, 2023
Optic neuritis associated with seronegative autoimmune encephalitis: a case report
Hyungseok Hah, Yonghyun Lee, Ho-Won Lee, et al.
Biomaterials
|
April 28, 2017
PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation
Min Jun Kim, Yonghyun Lee, Sangyong Jon, et al.
Biomacromolecules
|
May 2, 2018
Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy
Soyoung Lee, Yonghyun Lee, Hyungjun Kim, et al.
Pharmaceutics
|
November 4, 2020
Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
Yonghyun Lee, Jungyun Kim, Wooseong Kim, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
September 29, 2025
Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance
Xiaoliang Cheng, Peixing Wang, Hongqiang Lyu, et al.
Archives of Pharmacal Research
|
April 11, 2015
Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent
Wooseong Kim, Yonghyun Lee, Seongkeun Jeong, et al.
Angewandte Chemie (International Ed. in English)
|
May 5, 2016
Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy
Yonghyun Lee, Hyungjun Kim, Sukmo Kang, et al.
Page
of 7